Potential Antiviral Strategy Exploiting Dependence of SARS-CoV-2 Replication on Lysosome-Based Pathway
Overview
Chemistry
Molecular Biology
Affiliations
The recent novel coronavirus (SARS-CoV-2) disease (COVID-19) outbreak created a severe public health burden worldwide. Unfortunately, the SARS-CoV-2 variant is still spreading at an unprecedented speed in many countries and regions. There is still a lack of effective treatment for moderate and severe COVID-19 patients, due to a lack of understanding of the SARS-CoV-2 life cycle. Lysosomes, which act as "garbage disposals" for nearly all types of eukaryotic cells, were shown in numerous studies to support SARS-CoV-2 replication. Lysosome-associated pathways are required for virus entry and exit during replication. In this review, we summarize experimental evidence demonstrating a correlation between lysosomal function and SARS-CoV-2 replication, and the development of lysosomal perturbation drugs as anti-SARS-CoV-2 agents.
SARS-CoV-2 Is an Electricity-Driven Virus.
McCaig C Rev Physiol Biochem Pharmacol. 2025; 187():361-410.
PMID: 39838019 DOI: 10.1007/978-3-031-68827-0_18.
La Rosa P, Tiberi J, Palermo E, Stefanelli R, Tiano S, Canterini S Cell Biosci. 2024; 14(1):148.
PMID: 39707537 PMC: 11662611. DOI: 10.1186/s13578-024-01331-4.
Pathophysiology of COVID-19-Related Extrapyramidal Disorders.
Cavallieri F, Zedde M, Fioravanti V, Grisanti S, Napoli M, Moratti C Adv Exp Med Biol. 2024; 1457:111-123.
PMID: 39283423 DOI: 10.1007/978-3-031-61939-7_6.
Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle.
Woytinek K, Glitscher M, Hildt E J Virol. 2024; 98(7):e0058024.
PMID: 38856640 PMC: 11265270. DOI: 10.1128/jvi.00580-24.
pH-dependent endocytosis mechanisms for influenza A and SARS-coronavirus.
Aganovic A Front Microbiol. 2023; 14:1190463.
PMID: 37234537 PMC: 10206014. DOI: 10.3389/fmicb.2023.1190463.